Can-Fite BioPharma Announces $9M Registered Direct Offering; ~2.068M ADSs @$4.35/ADS

By: via Benzinga
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) today announced that it has entered into definitive agreements with institutional investors to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.